NorthWest Biotherapeutics Inc (NWBO)

[Basin Street Blues]

Currently a 'long only' institutional investor could reasonably command an allocation price of $1.20- $1.50 for 100m shares .

With data in hand and clinicians, KOL's and a truck load of seemingly regulatory
buy in , if our management cant get that done I assure you it would be 100% down to their lack of credibility .

A real money investor would spend several million dollars on their analysis and DD of the company and its data before putting up a single penny .

They would analyse every press release every word of every ASM , every promise made every time lines hit or missed, they would not leave a single stone unturned.

They would have third party expert consultants and i mean the best of the best pour over every line of the data and even have third parties re-assess all of their own findings and then make a decision based on all all of this.

The may then ask for conditions , like maybe the management return hundreds of millions of their options to the book, or maybe. increase the strike of the options.

They may insist on a restructuring of the board a revers split and a re-listing.

My own SWOT on my 9 1/2 year journey with North West has taken many turns but funnily enough right now the weakness that is Les's utter untrustworthiness and Linda Powers' ' absentee landlord ' status and their joint culture of blaming anyone and everyone but themselves for us being at an intrinsic $800m or less m/c strangely could present to an institutional investor as one less hurdle in a buy out situation because their exit would most certainly be part of any deal.